Positive Allosteric Modulators of Type 5 Metabotropic Glutamate Receptors (mGluR5) and Their Therapeutic Potential for the Treatment of CNS Disorders

Studies utilizing selective pharmacological antagonists or targeted gene deletion have demonstrated that type 5 metabotropic glutamate receptors (mGluR5) are critical mediators and potential therapeutic targets for the treatment of numerous disorders of the central nervous system (CNS), including de...

Descripción completa

Detalles Bibliográficos
Autores principales: Cleva, Richard M., Olive, M. Foster
Formato: Texto
Lenguaje:English
Publicado: MDPI 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3070661/
https://www.ncbi.nlm.nih.gov/pubmed/21368721
http://dx.doi.org/10.3390/molecules16032097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3070661/
https://www.ncbi.nlm.nih.gov/pubmed/21368721
http://dx.doi.org/10.3390/molecules16032097

Ejemplares similares